VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 624 filers reported holding VANECK VECTORS ETF TR in Q2 2020. The put-call ratio across all filers is 0.68 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,787,312 | -8.4% | 140,740 | +2.5% | 1.37% | -6.6% |
| Q2 2023 | $4,134,540 | -8.4% | 137,314 | -1.6% | 1.46% | -12.5% |
| Q1 2023 | $4,515,717 | +12.0% | 139,589 | -0.8% | 1.67% | +7.2% |
| Q4 2022 | $4,033,219 | +18.1% | 140,726 | -0.6% | 1.56% | +5.6% |
| Q3 2022 | $3,414,000 | -14.4% | 141,557 | -2.8% | 1.48% | -10.3% |
| Q2 2022 | $3,989,000 | -37.3% | 145,705 | -12.2% | 1.65% | -35.1% |
| Q1 2022 | $6,366,000 | +195.4% | 165,989 | +146.8% | 2.54% | +186.7% |
| Q4 2021 | $2,155,000 | -77.3% | 67,269 | -79.1% | 0.88% | -79.7% |
| Q3 2021 | $9,481,000 | -28.9% | 321,724 | -18.0% | 4.36% | -26.5% |
| Q2 2021 | $13,330,000 | +5.9% | 392,286 | +1.3% | 5.94% | -2.2% |
| Q1 2021 | $12,588,000 | +36.9% | 387,327 | +51.7% | 6.07% | +28.6% |
| Q4 2020 | $9,197,000 | +671.6% | 255,334 | +738.6% | 4.72% | +549.4% |
| Q3 2020 | $1,192,000 | +30.4% | 30,446 | +22.2% | 0.73% | +29.1% |
| Q2 2020 | $914,000 | +77.1% | 24,923 | +11.4% | 0.56% | +60.4% |
| Q1 2020 | $516,000 | -79.3% | 22,382 | -73.7% | 0.35% | -72.5% |
| Q4 2019 | $2,495,000 | +12.9% | 85,207 | +3.0% | 1.28% | +9.6% |
| Q3 2019 | $2,210,000 | – | 82,742 | – | 1.17% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 738,500 | $20,220,000 | 66.82% |
| Baymount Management LP | 145,000 | $3,970,000 | 28.08% |
| New Harbor Financial Group, LLC | 1,371,341 | $37,547,000 | 18.51% |
| New Harbor Financial Group, LLC | 1,291,700 | $35,366,000 | 17.44% |
| MKP Capital Management, L.L.C. | 1,500,000 | $41,070,000 | 13.74% |
| Windmill Hill Asset Management Ltd | 844,600 | $23,125,000 | 11.94% |
| Hollow Brook Wealth Management LLC | 768,567 | $21,043,000 | 11.57% |
| Grand Central Investment Group | 261,915 | $7,171,000 | 10.33% |
| Point72 Europe (London) LLP | 1,467,000 | $40,166,000 | 8.50% |
| Slate Path Capital LP | 4,600,000 | $125,948,000 | 7.87% |